Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
JNCI and cancer prevention.
Barbara K Dunn1, Sharmistha Ghosh2, Barnett S Kramer2
1Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD (BKD, SG, BSK). dunnb@mail.nih.gov.
The Journal of the National Cancer Institute (JNCI) has a history of publishing significant cancer prevention research, including landmark trials and studies on public health. Its publications cover diverse areas like tobacco cessation, chemoprevention, and nutrition.
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- The Journal of the National Cancer Institute (JNCI) has a long-standing reputation for publishing impactful research.
- It covers a wide spectrum of cancer research, from basic science to clinical applications.
Purpose of the Study:
- To highlight JNCI's historical contributions to cancer prevention and public health.
- To showcase the journal's role in disseminating practice-changing studies.
Main Methods:
- Review of landmark publications within JNCI.
- Analysis of studies on tobacco cessation, chemoprevention, and nutrition.
- Examination of key trials like the Breast Cancer Prevention Trial (BCPT).
Main Results:
- JNCI published the first large trial proving the efficacy of a preventive medication for a major malignancy (BCPT).
- The journal has featured critical analyses and discussions related to major chemoprevention trials (PCPT, SELECT).
- JNCI has addressed sensitive topics, contributing evidence on cancer risk factors.
Conclusions:
- JNCI has been a leading venue for disseminating pivotal research in cancer prevention.
- The journal's publications have significantly influenced cancer prevention strategies and public health initiatives.
- JNCI continues to be at the forefront of major publications in the field of cancer prevention.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

